Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating idiopathic thrombocytopenic purpura and application thereof

A composition and platelet technology, applied in the field of medicine, can solve the problems of affecting the blocking effect of immunoglobulin, weakening the male effect, and not being suitable for combined use, etc., and achieve the effects of low cost, good effect and stable quality control.

Inactive Publication Date: 2017-09-15
马宇振
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Corticosteroids can affect the blocking effect of immunoglobulins on macrophages, so they should not be used together
[0013] Danazol: (danazol, alkydroxydrostenyl isoxazole) is a synthetic androgen, but its androgenic effect has been weakened

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] A pharmaceutical composition for treating idiopathic thrombocytopenic purpura. The pharmaceutical composition comprises the following raw materials prepared in parts by weight: 31 parts of Codonopsis pilosula, 32 parts of Jiaobaizhu, 45 parts of Rehmannia glutinosa, 10 parts of Rehmannia glutinosa, 7 parts of paeonol 24 parts of buffalo horn, 42 parts of poria cocos, 20 parts of raw licorice, 14 parts of salvia miltiorrhiza, 19 parts of red peony root, 9 parts of Radix Ophiopogon japonicus and 9 parts of white peony root.

Embodiment 2

[0047] A pharmaceutical composition for treating idiopathic thrombocytopenic purpura, which comprises the following raw materials prepared in parts by weight: 9 parts of Codonopsis pilosula, 31 parts of Jiaobaizhu, 41 parts of Rehmannia glutinosa, 19 parts of Rehmannia glutinosa, 19 parts of Danpi 23 parts of buffalo horn, 41 parts of poria cocos, 5 parts of raw licorice, 31 parts of salvia miltiorrhiza, 7.5 parts of red peony root, 32 parts of Radix Ophiopogon japonicus and 9.8 parts of white peony root.

Embodiment 3

[0049] A pharmaceutical composition for treating idiopathic thrombocytopenic purpura, which comprises the following raw materials prepared in parts by weight: 10 parts of Codonopsis pilosula, 10 parts of Jiaobaizhu, 20 parts of Rehmannia glutinosa, 12 parts of Rehmannia glutinosa, 8 parts of paeonol 25 parts of buffalo horn, 15 parts of poria cocos, 6 parts of raw licorice, 15 parts of salvia miltiorrhiza, 8 parts of red peony root, 10 parts of Radix Ophiopogon japonicus and 10 parts of white peony root.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a pharmaceutical composition for treating idiopathic thrombocytopenic purpura and an application thereof. The pharmaceutical composition is prepared from codonopsis pilosula, deep-fried atractylodes macrocephala koidz, radix rehmanniae preparata, dried radix rehmanniae, cortex moutan, cornu bubali, poria cocos, licorice roots northwest origin, salviae miltiorrhizae, a red peony root, radix ophiopogonis and white peony root. The pharmaceutical composition has the advantages of being low in cost, good in effect on treatment of accurate and chronic idiopathic thrombocytopenic purpura, stable in quality control, natural, nontoxic, stable in effect and suitable for long-term medication.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to a pharmaceutical composition for treating idiopathic thrombocytopenic purpura and its application. Background technique [0002] Idiopathic thrombocytopenic purpura Western medicine clinical status: The main clinical features of idiopathic thrombocytopenic purpura are: spontaneous skin and mucous membrane bleeding; thrombocytopenia, normal or increased number of bone marrow megakaryocytes, prolonged bleeding time, poor blood clot contraction, bundles arm test positive. The disease is characterized by shortened platelet lifespan, increased megakaryocytes in the bone marrow with maturation disorders, and no obvious enlargement of the spleen. Its pathogenesis can be divided into low platelet production, excessive destruction and abnormal distribution. [0003] Idiopathic thrombocytopenic purpura is divided into two types: acute and chronic. [0004] The acute type occurs mostly ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P7/04A61K35/32
CPCA61K35/32A61K36/076A61K36/284A61K36/344A61K36/484A61K36/537A61K36/65A61K36/71A61K36/804A61K36/8968A61K2300/00
Inventor 马宇振马俊鹏邢盼盼马腾飞
Owner 马宇振
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com